Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy
Meeting Coverage > GICS — Median PFS in GEP-NETs increased from 11.5 to 29.7 with addition of lanreotide to everolimus...
Meeting Coverage > GICS — Median PFS in GEP-NETs increased from 11.5 to 29.7 with addition of lanreotide to everolimus...
This story is part of our ongoing “First Steps” series, where we share extraordinary stories of men who transformed their...